Silo Pharma
SILO
9 hedge funds and large institutions have $118K invested in Silo Pharma in 2024 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 3 closing their positions.
0% more funds holding
Funds holding: 9 → 9 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
0.05% less ownership
Funds ownership: 0.26% → 0.22% (-0.05%)
90% less capital invested
Capital invested by funds: $1.22M → $118K (-$1.1M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$71.3K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$3.81K |
| 3 |
RWMG
Redwood Wealth Management Group
Medford,
New Jersey
|
+$3.4K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$26 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FAIM
Financial Advocates Investment Management
Olympia,
Washington
|
-$66.3K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$729 |
| 3 |
FIM
FWL Investment Management
Dallas,
Texas
|
-$156 |
| 4 |
Wells Fargo
San Francisco,
California
|
-$33 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
VF
1
Virtu Financial
New York
| $41K | +$71.3K | +2,790 | New |
|
|
FAIM
2
Financial Advocates Investment Management
Olympia,
Washington
| $23.9K | -$66.3K | -2,591 | -62% |
|
3
Vanguard Group
Malvern,
Pennsylvania
| $16.3K | – | – | – |
|
4
Geode Capital Management
Boston,
Massachusetts
| $15.7K | – | – | – |
|
5
State Street
Boston,
Massachusetts
| $12.1K | – | – | – |
|
|
TRCT
6
Tower Research Capital (TRC)
New York
| $6.66K | +$3.81K | +149 | +51% |
|
|
RWMG
7
Redwood Wealth Management Group
Medford,
New Jersey
| $2K | +$3.4K | +133 | New |
|
|
WIM
8
Westside Investment Management
Santa Monica,
California
| $94 | – | – | – |
|
|
9
Bank of America
Charlotte,
North Carolina
| $17 | +$26 | +1 | New |
|
10
JP Morgan Chase
New York
| $1 | – | – | – |
|
|
11
UBS Group
Zurich,
Switzerland
| – | -$729 | -25 | Closed |
|
|
FIM
12
FWL Investment Management
Dallas,
Texas
| – | -$156 | -5 | Closed |
|
|
13
Wells Fargo
San Francisco,
California
| – | -$33 | -1 | Closed |
|
SILO Hedge Fund Activity: Q2 2024 in Review
9 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in Silo Pharma (SILO) for Q2 2024, worth a combined $118K — down 90% from $1.22M a quarter earlier.
Fund positioning in SILO was balanced in Q2 2024: 3 funds opened new positions, 3 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was Virtu Financial, opening a new position worth an estimated $71.3K. The largest seller was Financial Advocates Investment Management, cutting an estimated $66.3K.
- 9 institutional investors held Silo Pharma (SILO) as of Q2 2024, unchanged from Q1 2024.
- Funds reported $118K of Silo Pharma stock for Q2 2024, down 90% quarter-over-quarter.
- 3 funds opened new Silo Pharma positions in Q2 2024 and 3 closed out, a net change of 0 holders.
- The largest Silo Pharma buyer in Q2 2024 was Virtu Financial, an estimated $71.3K added.
- The largest Silo Pharma seller in Q2 2024 was Financial Advocates Investment Management, an estimated $66.3K sold.
Based on aggregated 13F filings for Q2 2024.